Newborns, particularly those born prematurely or with congenital anomalies, are at a higher risk of developing cardiovascular issues. Cardiac biomarkers can help in the early detection of heart-related problems, enabling timely intervention and improving outcomes. They are especially useful in diagnosing conditions like neonatal sepsis, congenital heart disease, and perinatal asphyxia.
